335P Resistance to CDK4/6 inhibitors: Clinical practice use of liquid biopsy to identify KRAS-mutations in ctDNA and overexpression of CDK9 in plasma derived exosomes. - Raimondi, L.; Pietranera, M.; Spinelli, G.P. (Annals of Oncology, 2020)